Skip to Content

3138 WPI (Nizatidine 300 mg)

Pill with imprint 3138 WPI is Brown, Capsule-shape and has been identified as Nizatidine 300 mg. It is supplied by Watson Pharmaceuticals.

Nizatidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; indigestion (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 3138 WPI

Nizatidine 300 mg 3138 WPI

Nizatidine

Imprint:
3138 WPI
Strength:
300 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
silicon dioxide colloidal
corn starch
croscarmellose sodium
magnesium stearate
pregelatinized corn starch
ammonia
ferric oxide black
gelatin
potassium hydroxide
propylene glycol
shellac
silicon dioxide
sodium lauryl sulfate
titanium dioxide
ferric oxide red
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide